Reckitt Benckiser: UBS still a buyer, but cuts TP

(CercleFinance.com) - UBS reinstates its its 'buy' recommendation on Reckitt Benckiser shares, while reducing its target price for them from 8,300p to 8,000p, which still means upside potential of 40% for the UK health and home care group's shares.


"Soft set of numbers and cautious H2 outlook should not overshadow the fact that RKT remains well on track to being again a reliable compounder," the broker said, for which "China & inflation masking underlying progress".


Copyright (c) 2021 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.